277 related articles for article (PubMed ID: 21619856)
1. Viral safety in homoeopathic medicinal products.
Schultz N; Franck-Karl G; Schilk J; Rose N
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
[TBL] [Abstract][Full Text] [Related]
2. Viral safety evaluation of biopharmaceuticals and homoeopathic preparations of human or animal origin.
Immelmann A
Pharmeur Sci Notes; 2006 Aug; 2006(1):41-5. PubMed ID: 17694646
[TBL] [Abstract][Full Text] [Related]
3. [Certification of suitability of monographs of the European pharmacopoeia].
Artiges A
Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
[TBL] [Abstract][Full Text] [Related]
4. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
Bruckner L
Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
[TBL] [Abstract][Full Text] [Related]
5. Study of the risk of heavy metal transfer to homoeopathic mother tinctures.
Busch J; Werner W; Huwer A
Pharmeur Bio Sci Notes; 2012 Apr; 2012():55-71. PubMed ID: 23327892
[TBL] [Abstract][Full Text] [Related]
6. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
Vlietinck A; Pieters L; Apers S
Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
[TBL] [Abstract][Full Text] [Related]
7. Risk reduction in biotherapeutic products.
Ill CR; Dehghani H
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
[TBL] [Abstract][Full Text] [Related]
8. European Union directives and their effect on the registration and authorisation of anthroposophic and homeopathic medicines.
Laso LR; Alfonso-Galán MT
Med Law; 2009 Mar; 28(2):269-82. PubMed ID: 19705642
[TBL] [Abstract][Full Text] [Related]
9. [Viral safety: European and French directives].
Rossi F; Legras JF
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S55-61. PubMed ID: 10896992
[TBL] [Abstract][Full Text] [Related]
10. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
[TBL] [Abstract][Full Text] [Related]
11. Worldwide perspective in transfusion safety: Europe.
Reesink HW; Strengers PE
Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
[No Abstract] [Full Text] [Related]
12. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
Jungbäck C; Motitschke A
Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
[TBL] [Abstract][Full Text] [Related]
13. Regulation of medicinal plants for public health--European community monographs on herbal substances.
Knöss W; Chinou I
Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
[TBL] [Abstract][Full Text] [Related]
14. The regulatory system in europe with special emphasis on allergen products.
Lorenz AR; Luttkopf D; Seitz R; Vieths S
Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
[TBL] [Abstract][Full Text] [Related]
15. Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework.
Buchholzer ML; Werner C; Knoess W
Regul Toxicol Pharmacol; 2014 Mar; 68(2):193-200. PubMed ID: 24384395
[TBL] [Abstract][Full Text] [Related]
16. [Viral safety of biological medicinal products].
Stühler A; Blümel J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1198-202. PubMed ID: 25123140
[TBL] [Abstract][Full Text] [Related]
17. The current global status of Chinese materia medica.
Liu X; Zou J; Sheng Z; Su G; Chen S
Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
[TBL] [Abstract][Full Text] [Related]
18. [Special therapeutic guidelines from the viewpoint of BfArM (Federal Institute for Drug and Medical Products)].
Keller K
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):669-74. PubMed ID: 9527466
[TBL] [Abstract][Full Text] [Related]
19. The harmonization of the regulation of blood products: a European perspective.
Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
[TBL] [Abstract][Full Text] [Related]
20. Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan.
Chang LC; Kang JJ; Gau CS
Regul Toxicol Pharmacol; 2016 Jun; 77():252-6. PubMed ID: 27016398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
